Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Johnson and Johnson completes sale of Ortho-Clinical Diagnostics

Johnson and Johnson completes sale of Ortho-Clinical Diagnostics

7th July 2014

Johnson and Johnson has announced the completion of the $4 billion (2.34 billion pounds) divestiture of its Ortho-Clinical Diagnostics business.

The company has sold off the unit to the Carlyle Group, a decision that was confirmed in March 2014 following consultation with the relevant works councils and trade unions. The financial impact of the deal will be discussed in Johnson and Johnson's quarterly earnings call next week.

Ortho-Clinical Diagnostics is a leading global provider of solutions for screening, diagnosing, monitoring and confirming diseases. Its business generated net sales of approximately $1.9 billion in 2013.

Following its purchase by the asset management group, it will operate as a free-standing enterprise with a new leadership structure led by Dr Martin Madaus. It has already committed to increasing its investment in research and development.

This comes as part of Johnson and Johnson's commitment to a wider portfolio management strategy that delivers the maximum value to shareholders.ADNFCR-8000103-ID-801733790-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.